Annual Total Expenses
$207.92 M
+$15.74 M+8.19%
31 December 2023
Summary:
Xeris Biopharma Holdings annual total expenses is currently $207.92 million, with the most recent change of +$15.74 million (+8.19%) on 31 December 2023. During the last 3 years, it has risen by +$103.94 million (+99.96%). XERS annual total expenses is now at all-time high.XERS Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$67.16 M
+$10.91 M+19.39%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly total expenses is currently $67.16 million, with the most recent change of +$10.91 million (+19.39%) on 30 September 2024. Over the past year, it has increased by +$13.93 million (+26.16%). XERS quarterly total expenses is now -3.64% below its all-time high of $69.70 million, reached on 31 December 2021.XERS Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.2% | +26.2% |
| 3 y3 years | +100.0% | +89.6% |
| 5 y5 years | +236.6% | +121.0% |
XERS Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +100.0% | -3.6% | +89.6% |
| 5 y | 5 years | at high | +236.6% | -3.6% | +190.1% |
| alltime | all time | at high | +1353.4% | -3.6% | +1242.4% |
Xeris Biopharma Holdings Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $67.16 M(+19.4%) |
| June 2024 | - | $56.25 M(+2.5%) |
| Mar 2024 | - | $54.88 M(+1.2%) |
| Dec 2023 | $207.92 M(+8.2%) | $54.23 M(+1.9%) |
| Sept 2023 | - | $53.23 M(-1.4%) |
| June 2023 | - | $53.99 M(+16.2%) |
| Mar 2023 | - | $46.47 M(-3.8%) |
| Dec 2022 | $192.19 M(+16.7%) | $48.31 M(-0.4%) |
| Sept 2022 | - | $48.51 M(+9.7%) |
| June 2022 | - | $44.22 M(-13.5%) |
| Mar 2022 | - | $51.15 M(-26.6%) |
| Dec 2021 | $164.75 M(+58.4%) | $69.70 M(+96.8%) |
| Sept 2021 | - | $35.42 M(+2.1%) |
| June 2021 | - | $34.69 M(+39.1%) |
| Mar 2021 | - | $24.93 M(-6.7%) |
| Dec 2020 | $103.98 M | $26.71 M(+15.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $23.15 M(-4.5%) |
| June 2020 | - | $24.23 M(-19.0%) |
| Mar 2020 | - | $29.93 M(-13.7%) |
| Dec 2019 | $125.10 M(+102.5%) | $34.66 M(+14.0%) |
| Sept 2019 | - | $30.39 M(-11.5%) |
| June 2019 | - | $34.36 M(+33.8%) |
| Mar 2019 | - | $25.68 M(+21.9%) |
| Dec 2018 | $61.77 M(+119.1%) | $21.07 M(+35.7%) |
| Sept 2018 | - | $15.53 M(+17.8%) |
| June 2018 | - | $13.18 M(+9.9%) |
| Mar 2018 | - | $11.99 M(+23.9%) |
| Dec 2017 | $28.18 M(+97.0%) | $9.68 M(+25.0%) |
| Sept 2017 | - | $7.74 M(+34.3%) |
| June 2017 | - | $5.76 M(+15.2%) |
| Mar 2017 | - | $5.00 M |
| Dec 2016 | $14.31 M | - |
FAQ
- What is Xeris Biopharma Holdings annual total expenses?
- What is the all time high annual total expenses for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual total expenses year-on-year change?
- What is Xeris Biopharma Holdings quarterly total expenses?
- What is the all time high quarterly total expenses for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly total expenses year-on-year change?
What is Xeris Biopharma Holdings annual total expenses?
The current annual total expenses of XERS is $207.92 M
What is the all time high annual total expenses for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual total expenses is $207.92 M
What is Xeris Biopharma Holdings annual total expenses year-on-year change?
Over the past year, XERS annual total expenses has changed by +$15.74 M (+8.19%)
What is Xeris Biopharma Holdings quarterly total expenses?
The current quarterly total expenses of XERS is $67.16 M
What is the all time high quarterly total expenses for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly total expenses is $69.70 M
What is Xeris Biopharma Holdings quarterly total expenses year-on-year change?
Over the past year, XERS quarterly total expenses has changed by +$13.93 M (+26.16%)